Anti-p53 antibody [EPR17343]
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- 20ul selling size
- What is this?
3
(2 Reviews)
|
(46 Publications)
Rabbit Recombinant Monoclonal P53 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 46 publications.
View Alternative Names
P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [EPR17343] (AB179477)
ab179477 staining p53 in wild-type HAP1 cells (top panel) and p53 knockout HAP1 cells (bottom panel). The cells were fixed with methanol (5min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab179477 at 1/500 dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
- WB
Supplier Data
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : HL-60 (p53 null), NCI-H1299 (p53 null).
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 21941372, PMID : 21779513, PMID : 25996291).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-p53 antibody [DO-1] - ChIP Grade (ab1101) staining at 1/1000 dilution.
In Western blot, Anti-p53 antibody [EPR17343] (ab179477) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (<a href='/en-us/products/primary-antibodies/tp53-phospho-s376s377s392-antibody-rm1161-ab322465'>ab322465</a>) at 1/1000 dilution
Lane 1:
Untreated HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HCT 116 treated with 20uM etoposide for 15 hours whole cell lysate at 20 µg
Lane 3:
Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
A549 treated with 500nM doxorubicin for 24 hours whole cell lysate at 20 µg
Lane 5:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
HL-60 (human acute promyelocytic leukemia promyeloblast) whole cell lysate at 20 µg
Lane 7:
NCI-H1299 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 53 kDa,26-48 kDa,36 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
Blocking/dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/20000 dilution
All lanes:
T-47D (Human ductal breast epithelial carcinoma cell line) whole cell lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 43 kDa
Observed band size: 44 kDa,53 kDa
false
- WB
Lab
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
Western blot : Anti-p53 antibody [EPR17343] ab179477 staining at 1/2000 dilution, shown in green; Mouse anti-CANX ab238078 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 50 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in TP53 knockout MCF7 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween™ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution
Lane 1:
Wild-type MCF7 whole cell lysate at 20 µg
Lane 2:
Western blot - Human TP53 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-tp53-knockout-mcf7-cell-line-ab286440'>ab286440</a>) at 20 µg
Lane 3:
Wild-type A549 whole cell lysate at 20 µg
Lane 4:
TP53 knockout A549 whole cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
- WB
Supplier Data
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
Blocking and Diluting buffer and concentration : 5% NFDM/TBST.
Saos-2, PC-3 and HL-60 cells are p53 null cell lines.
All lanes:
Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution
Lane 1:
HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysates at 20 µg
Lane 2:
A431 (Human epidermoid carcinoma) whole cell lysates at 20 µg
Lane 3:
Saos-2 (Human osteosarcoma cell line) whole cell lysates at 20 µg
Lane 4:
HL-60 (Human promyelocytic leukemia cells) whole cell lysates at 20 µg
Lane 5:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 43 kDa
Observed band size: 44 kDa
false
- WB
Lab
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : p53 knockout HAP1 cell lysate (20 μg)
Lane 3 : A431 cell lysate (20 μg)
Lane 4 : Saos-2 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab179477 observed at 53 kDa. Red - loading control, ab8226, observed at 42 kDa.
ab179477 was shown to specifically react with p53 in wild type HAP1 cells along with additional cross reactive bands. No band was observed with p53 knockout samples were used.
Wild-type and p53 knockout samples were subjected to SDS-PAGE. ab179477 and ab8226 (loading control to beta Actin) were diluted to 1/2000 and 1/1000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-p53 antibody [EPR17343] (ab179477)
Predicted band size: 43 kDa
false
- WB
Lab
Western blot - Anti-p53 antibody [EPR17343] (AB179477)
All lanes:
Western blot - Anti-p53 antibody [EPR17343] (ab179477) at 1/2000 dilution
Lane 1:
Untreated HCT 116 (Human colorectal carcinoma) whole cell lysate
Lane 2:
HCT 116 (Human colorectal carcinoma) whole cell lysate with 0.5μM Doxorubicin for 24hours whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 53 kDa
false
Related conjugates and formulations (1)
-
Anti-p53 antibody [EPR17343] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.
Pathways
P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (46)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules & therapeutics 33:365-377 PubMed39989046
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental pharmacology & physiology 52:e70022 PubMed39788129
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 14:1471109 PubMed39582546
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 28:320 PubMed38939173
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 16:690-699 PubMed38463590
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 67:71-92 PubMed38286301
2024
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23159 PubMed37650687
2023
Applications
Unspecified application
Species
Unspecified reactive species
Immunity, inflammation and disease 11:e973 PubMed37584301
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 27:81 PubMed36180832
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 24:545 PubMed35978936
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com